The long-term objectives of this project continue to be the facilitation of high quality clinical research and compliance with federal and local regulations. In addition, we will partner with M.D. Anderson Cancer Center - Orlando, a community based regional center just beginning a new cancer research program to extend the benefits of our advances in human subjects protection. 1. The mandatory faculty-training course has been designed and implemented. We will continue to offer it to new faculty and fellows. We will develop new modules to update all faculty on regulatory chanl;es (e.g., HIPAA and conflict-of-interest policy changes). 2. Complete an integrated process to allow comparison of information in the conflict-of-interest (COI) database developed under the previous award with both the clinical research database (Protocol Data Management System, PDMS) which contains the names of all principal and coinvestigators on human subject research protocols and the protocol authoring data base (Protocol Document On-Line System, PDOL) which contains the informed consent documents. 3. Implement the next critical phase of the Clinical Oncology Research (CORe) Oracle-based system, the electronic continuing review process. 4. Create a new functionality in the PDOL system that will allow the attachment of various word processing file types to any protocol document, thus allowing protocols that are received from outside the institution to be incorporated into the protocol database. 5. Partner with M.D. Anderson Cancer Center - Orlando (MDACC-Orlando) in the development of their clinical research program by training MDACC-Orlando investigators, research nurses, and data managers using our training program and providing Orlando access to registration on clinical trials over the world wide web via the PDMS system and access to all our IRB standard operating procedures.
Zwelling, Leonard A; Brunelli, Carleen A (2007) Strategies for the administration of a clinical trials infrastructure: lessons from a comprehensive cancer center. Cancer Treat Res 132:241-74 |